← All Sponsors
SPONSOR

Centers for Disease Control and Prevention

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Latent Tuberculosis
NCT03474029 Phase 2, Phase 3
Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Latent Tuberculosis
United States, Australia, Canada View Trial →